New drug combo trial aims to fight tough uterine cancer
NCT ID NCT07170982
Summary
This study is testing if adding a drug called fruquintinib to standard chemotherapy works better than chemotherapy alone for treating advanced endometrial cancer that has not spread to other parts of the body. About 128 patients will be randomly assigned to receive either the new combination or standard care. The main goal is to see if the combination makes tumors shrink more often and for longer, but patients will need to continue treatment to keep the cancer under control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.